Chemokine Therapeutics Corp.
U.S. patent allowed for novel cancer drug in clinical development
Published in Drug Law Weekly, July 26th, 2005
CTCE-9908 is designed to block CXCR4, a receptor found on the surface of cancer cells. CTCE-9908 inhibits the growth and spread of certain common cancers, with the potential for use with existing therapies (chemotherapy, surgery, and radiation) to improve treatment outcomes.
The patent entitled "Therapeutic Chemokine Receptor Antagonists", with a term lasting to August 2019, covers some of the methods by which CTCE-9908 treats cancer. It...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Law Weekly
Source: Drug Law Weekly (2005-07-26)
More Articles from Drug Law Weekly
- Frost & Sullivan
Consultancy releases study on pharma industry - Generex Biotechnology Corp.
Drug-delivery company gets Mexican patent - Hacettepe University, Ankara
N-acetylcysteine treatment has no prophylactic use - Medtronic, Inc.
Technology company purchases land for new headquarters, launches online resource - Myriad Genetics, Inc.
Biopharmaceutical company announces patent on amyloid lowering drugs - National Prostate Cancer Coalition
ED drug amendment passage puts lives at risk, says prostate cancer organization - More from this issue of Drug Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
